Clinical Diagnostics Automation Market Scope
Clinical diagnosis automation offers precise operations in the field of medical diagnosis. There are various advantages associated with clinical diagnosis automation such as affordable treatment, safer solutions, fast service with high accuracy, longer-lasting equipment, less risk of lawsuits and many others. Advancements in newborn screening & breast cancer advances and technological developments in ebola diagnostics due to the growing emergence of an ebola outbreak have been supplementing the overall growth of the market. However, lack of adoption of clinical diagnostic automation among small and medium-sized laboratories and higher initial investments, as well as expensive sensors, might stagnate the demand for clinical diagnostic automation.
The market study is being classified by Type (Modular Automation and Total Lab Automation), by Application (Clinical Diagnostics, Drug Discovery, Proteomics Solutions and Others) and major geographies with country level break-up.
The Players having a strong hold in the market are Abaxis, Abbott Diagnostics, Beckman Coulter, Becton, Dickinson, and bioMrieux SA. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Diagnostics Automation market throughout the predicted period.
Abaxis, Inc. (United States), Abbott Diagnostics, Inc. (United States), Beckman Coulter, Inc. (United States), Becton, Dickinson, and Company (United States), bioMrieux SA (France), Bio-Rad Laboratories, Inc. (United States), Diagnostica Stago S.A.S. (France), Eppendorf AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), HORIBA ABX S.A.S. (France), Hudson Robotics, Inc. (United States) and Ortho Clinical Diagnostics, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are PerkinElmer Inc. (United States), QIAGEN NV (Netherlands), Siemens Healthineers (United States), Sysmex America, Inc. (United States), Tecan Group Ltd. (Switzerland), The ELITechGroup SAS (France) and Thermo Fisher Scientific, Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Clinical Diagnostics Automation market by Type, Application and Region.
On the basis of geography, the market of Clinical Diagnostics Automation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Software, the sub-segment i.e. Automated liquid handling will boost the Clinical Diagnostics Automation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On May 6, 2019, Abbott has launched a new, smarter heart monitor for better arrhythmia detection positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for a fast and accurate diagnosis.
- Upsurging Advancements in Newborn Screening & Breast Cancer Advances
- Upsurging Technological Developments in Ebola Diagnostics due to the growing emergence of an Ebola outbreak
- Upsurging Demand for Accurate Clinical Diagnostics
- Growing Geriatric Population across the Globe
- Emerging Markets Provide an Array of Opportunities to Clinical Diagnostics System Providers
- Wide Scope and Increasing Adoption in Microbiology
- Lack of Adoption of Clinical Diagnostic Automation among Small and Medium-Sized Laboratories
- Higher Initial Investments, as well as Expensive Sensors, might Stagnate the Demand
- Complexities in Technological Installment and Existing System Integrations
- Skilled Workforce required in Developing Highly Automated Systems
Key Target AudienceClinical Diagnostics Automation Service Providers, Clinical Diagnostics Service Providers, Upstream and Downstream Buyers, Government Agencies, Research and Development Institutes and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase